Trial intelligence / Profile preview

Natesto vs Testosterone Cypionate in Male Hypogonadism

NCT04439799Phase 4Completed

Sponsor
University of Miami
Start
Aug 2020
Primary completion
Feb 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of natesto in Hypogonadism, sponsored by University of Miami. Started Aug 2020; status: completed.

02

Drugs

natesto
03

Conditions

Hypogonadism

Beyond the preview

Go deeper on NCT04439799.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04439799.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call